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Most biliary tract neoplasms are malignant and have been
traditionally divided into cancers of the gallbladder, the
extrahepatic bile ducts, and ampulla of Vater. Although
infrequent, bile duct carcinomas and cancer of the
gallbladder are not rare. In the United States, an estimated
6,000 to 7,000 new cases of carcinoma of the gallbladder
and 3,000 to 4,000 new cases of carcinoma of the bile
ducts are diagnosed annually. Familiarity with the imaging
characteristics of gallbladder and bile duct neoplasms is
important to expedite diagnosis and appropriate treatment
of patients who often present with nonspecific symptoms
of right upper quadrant pain, jaundice, and weight loss.
This workshop presents the CT and ultrasound features of
biliary tract neoplasms important for early diagnosis,
staging, and follow-up of these often lethal neoplasms
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